An Investigational Immunotherapy Study of BMS-986299 Alone and in Combination With Nivolumab and Ipilimumab in Participants With Solid Cancers That Have Spread or Cannot be Removed

Local Institution, Detroit

Washington University, St Louis

MD Anderson Cancer Center, Houston

Local Institution, Orange

University of California Davis Medical Center, Sacramento

Local Institution, Portland

Local Institution - 0003, La Jolla

Local Institution, New Haven

Local Institution, Pittsburgh